Observational studyFrontiers in immunology2026
Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study.
Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the western world. Its pathophysiology is intertwined with immune dysfunction. Emerging evidence suggests an inverse association between serum immunoglobulin E (IgE) and hematologic malignancies, but previous studies linking low IgE to CLL risk were limited by small cohorts and a lack of adjustment for confounding factors, particularly hypogammaglobulinemia. Purpose: This study aimed to evaluate the association between low serum IgE levels and the future development of CLL in a large, real-world cohort, while accounting for other immunoglobulins and confounding factors. Methods: We conducted a retrospective quantitative observational study of 118,740 adults from a large health maintenance organization. The primary exposure was a baseline IgE level of less than 25 IU/mL. We used Kaplan-Meier curves and a multivariable Cox proportional hazards model to assess the association between low IgE and CLL diagnosis over a seven-year follow-up period, adjusting for age, sex, and other potential confounders, including hypogammaglobulinemia and atopy-related conditions. Results: A serum IgE level of less than 25 IU/mL was significantly associated with an increased hazard of developing CLL (HR = 1.94, 97.5% CI: 1.47-2.56). This association persisted after adjusting for all confounding variables. Established risk factors, such as older age (HR = 1.07) and male sex (HR = 1.82), were also significant. Kaplan-Meier curves showed a sustained and a statistically significant increased risk in the low IgE group throughout the follow-up period. Conclusion: Lower serum IgE levels are independently associated with an increased risk of developing CLL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.